Colinz Labs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE923C01011
  • NSEID:
  • BSEID: 531210
INR
72.22
-3.8 (-5.0%)
BSENSE

Feb 03

BSE+NSE Vol: 1.18 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Colinz Labs
Span Divergent
Desh Rakshak
Ishita Drugs
Shree Ganesh Bio
Zenith Health
ANG Lifesciences
Chandra Bhagat
Venmax Drugs
Starsource Multi
Mono Pharmacare
Why is Colinz Laboratories Ltd ?
1
Weak Long Term Fundamental Strength with a -2.31% CAGR growth in Net Sales over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.37
  • The company has been able to generate a Return on Equity (avg) of 4.90% signifying low profitability per unit of shareholders funds
2
Flat results in Sep 25
  • OPERATING CF(Y) Lowest at Rs -1.45 Cr
  • DEBTORS TURNOVER RATIO(HY) Lowest at 0.76 times
3
With ROE of 4.7, it has a Expensive valuation with a 1.9 Price to Book Value
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -31.71%, its profits have fallen by -9%
4
Below par performance in long term as well as near term
  • Along with generating -31.71% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Colinz Labs for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Colinz Labs
32.49%
-0.54
58.90%
Sensex
8.49%
0.44
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-1.13%
EBIT Growth (5y)
3.01%
EBIT to Interest (avg)
0.37
Debt to EBITDA (avg)
0.63
Net Debt to Equity (avg)
-0.68
Sales to Capital Employed (avg)
0.75
Tax Ratio
16.67%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.95%
ROE (avg)
4.90%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
39
Industry P/E
32
Price to Book Value
1.94
EV to EBIT
12.39
EV to EBITDA
12.39
EV to Capital Employed
3.97
EV to Sales
2.12
PEG Ratio
0.76
Dividend Yield
NA
ROCE (Latest)
7.37%
ROE (Latest)
4.96%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-3What is not working for the Company
ROCE(HY)

Lowest at 5.88%

Loading Valuation Snapshot...